Explore insights, news, and background stories from the Greater Zurich Area – one of Europe’s most advanced business and innovation hubs. This is where international companies, tech pioneers, and investors find the latest updates on artificial intelligence, robotics, biotech, fintech, and more. Whether you're looking for real-world expansion cases, startup success stories, or key developments in Switzerland’s business environment, our articles offer firsthand perspectives and strategic guidance.
Ava bracelet approved in the USA
Zurich - The United States Food and Drug Administration (FDA) has approved a bracelet developed by the MedTech firm Ava for the US market. This is the first and only wearable device that determines fertile days in women to have received FDA clearance.
Migros invests in Selma Finance
Zurich/Arth SZ - Sparrow Ventures, the venture capital arm of the Migros Group, has taken part in a financing round conducted by Selma Finance, a digital asset management firm based in the Greater Zurich Area. In addition, Migros Bank and the FinTech firm have agreed terms on a partnership.
Sevensense co-founder praises robotics scene in Switzerland
Zurich – Switzerland is fertile ground for robotics startups, says Roland Siegwart. The ETH Professor and co-founder of the startup Sevensense highlights the specialist expertise in precision mechanics and sensor technologies in the country.
Microlino successor model coming
Küsnacht ZH – The Microlino electric city car has been street legal across Europe since summer 2018. Now, Micro Mobility Systems AG is working on the successor model. The Microlino 2.0 boasts better handling characteristics, among other improvements.
Systemcredit secures new funding
Schlieren ZH – Systemcredit has raised a total of 400'000 Swiss francs in a funding round. The fintech brokers loans for SMEs on its platform. The funding will help it to expand its platform.
SEBA Bank makes cryptocurrency trading easier
Zug – Cryptocurrency specialist SEBA Bank has agreed a collaboration with ED&F Man Capital Markets. Traders will consequently benefit from a custody and margin payment solution.
First patient treated with Orpha Labs' drug
Baar ZG – This week, the first patient was treated in Israel with a drug developed by Orpha Labs to combat the rare disorder leukocyte adhesion deficiency type II (LAD II). In particularly serious cases, a special program can be used to grant patients access to this new, highly promising drug even before it has been officially authorized.
Helvetia invests in start-up Taxly
Zurich/St.Gallen - The Helvetia Venture Fund has invested in Taxly, a start-up active in the emerging field of TaxTech. Its software is designed to allow users to complete and file tax returns within a matter of minutes. Taxly is now keen to expand by offering its product beyond the cantons of Zurich, Aargau, St.Gallen and Basel-Landschaft.
Pharvaris seeks to generate increased IPO proceeds
Zug - The BioTech firm Pharvaris has increased the initial issue price of its ordinary shares for the company’s IPO in the USA. Gross proceeds are now expected to total approximately 165 million US dollars overall. In addition, Pharvaris has granted the underwriting banks an overallotment option.
Meet with an expansion expert
Is Greater Zurich on your expansion radar? We support you on every step of your expansion journey - from location evaluation to fact finding visits.
Our services are free of charge and include:
- Introduction to key contacts in industry, academia, and government
- Location evaluation support to find the ideal base for your business
- Advice on regulatory framework, taxes, labor, market, and setting up a company
- Custom-made fact-finding visits, including office and co-working space
- And much more, customized to meet your needs.